Bills › 89th General Assembly
Relating to experimental treatments for terminally ill persons, and including effective date provisions
Topics:Health care
Where it is now
- Done: IntroducedJanuary 11, 2022
- Done: SubcommitteeJanuary 11, 2022
- Done: House committeeJanuary 27, 2022
- Skipped: Passes the HouseContinued as HF 2203
- Next: Senate committee
- Next: Passes the Senate
- Next: To the Governor
- Next: Signed into law
Became HF 2203 → Its progress continues under the new number. Go to HF 2203 What’s a funnel?
What’s in it
AI summary People who are terminally ill and using a breathing machine to stay alive can now qualify for experimental medical treatments. The law also expands what counts as an experimental drug or device to include using medicine for a purpose other than what it was originally approved for. Finally, the rules change which doctors are required to help manage these treatments for the patient.1
Read the official explanation
This bill relates to experimental treatments for terminally ill persons. The bill expands the definition of “eligible patient” to include a person who is receiving mechanical ventilation to prolong life. The bill also expands the definition of an “investigational drug, biological product, or device” to include the off-label use of a drug as defined in the bill. The bill replaces the current required involvement of the patient’s physician or the patient’s treating physician to instead require involvement from a physician or a treating physician to fulfill certain duties. The bill takes effect upon enactment.
Changed since by amendments H-8105, H-8053; see Amendments.
House subcommittee
Named January 11, 2022. On January 25, 2022 it recommended passage. Vote Total: 2-1.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Iowa Code it changes
Lobbying
3 for · 3 against · 22 undecided · Who →